Objective: To study changes of neuropeptides and adipokines in cerebrospinal fluid (CSF) and serum from pregnancy to postpregnancy in relation to weight changes, fat mass and glucose metabolism.
| INTRODUCTION
Women who gain more weight during pregnancy than recommended by the Institute of Medicine retain significantly more weight postpartum than women who do not, independent of prepregnancy BMI or body fat at baseline. 1 Mean body weight decreases within a year after pregnancy and increases thereafter. Even so, 1 year after pregnancy, 56% of women have gained up to 5 kg, and 13% of women have gained up to 5-10 kg. 2 Excess pregnancy weight retention and failure to lose weight in a reasonable time are risk factors for overweight and obesity in midlife up to 15 years after pregnancy.
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Numerous studies have analysed factors explaining weight development after pregnancy and delivery, with a range of subjects from several hundred thousand women to fewer than one-hundred, but overall it has been surprisingly difficult to identify strong predictors of weight development. How the body regulates gestational weight gain and why some women gain excessive weight after pregnancy is not known. Factors that may predict development of obesity in later life mainly include gestational weight gain, prepregnancy nutritional status, age, parity and race. Change in lifestyle factors, such as eating habits, enrolment in physical activity, smoking and duration of lactation, in addition to the above factors, may also contribute to the weight gain but are still not fully explaining the development of obesity. 4 Food intake and energy expenditure are primarily controlled by the central nervous system (CNS). The hypothalamus is the primary brain region regulating energy homoeostasis. The arcuate nucleus, a key hypothalamic area involved in food intake and body weight, has two neuronal populations with opposite effects on food intake:
neurons co-expressing agouti-related protein (AgRP) and neuropeptide Y, which stimulate food intake, and neurons that when activated express pro-opiomelanocortin, which inhibits food intake. AgRP neurons respond to metabolic signals that regulate energy and glucose homoeostasis, including leptin and insulin. 5 This system has been investigated in rodents, but human studies have been limited by the lack of biomarkers for brain AgRP. Plasma AgRP was evaluated as a marker of hypothalamic AgRP activity and suggested to be linked to insulin sensitivity. 6 Previously, we found that placental production of AgRP and serum (s) AgRP levels increased throughout pregnancy but with great interindividual variation. Cerebrospinal fluid (CSF) AgRP, leptin and insulin concentrations were higher, and the s-AgRP concentration was lower, in overweight and obese women than in those of normal weight.
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Thus, both central and peripheral AgRPs may interact with effects of leptin and insulin to meet the physiological and metabolic demands of pregnancy. Neurotransmitters might have an important role involved in body weight-regulating neural pathways. Surprisingly, no study has to our knowledge investigated neuropeptides after pregnancy and how it differs in weight-stable women and those who gained weight compared with start of pregnancy.
We hypothesize that neuropeptides levels in late pregnancy might predict weight change, fat mass and insulin sensitivity 5 years after pregnancy and might be potential biomarkers for their elevated risk of weight gain. To test this hypothesis, we studied women in a nonpregnant state and longitudinally compared their weight, fat mass and insulin sensitivity (HOMA-IR) in relation to CSF and serum levels of AgRP, leptin, insulin and adiponectin during and after pregnancy.
| METHODS

| Subjects
The study was approved by the ethical committee at the University of Gothenburg (dnr 402-08/dnr 750-15). Informed consent was obtained from all participants. All 74 women from our earlier study 7 were contacted by phone, and 25 agreed to participate in this follow-up study. The cohort is depicted in Figure 1 . There was no difference in BMI, age or gestational weight gain between women who chose to participate in the follow-up study and those who did not.
Inclusion was originally made at admission for elective caesarean.
This group was chosen asCSF samples can conveniently be obtained in preparation for spinal anaesthesia. Inclusion criteria were uncomplicated pregnancy and good health, judged from the medical history. At entry, all subjects were normoglycemic, nonsmokers, and did not consume alcohol. Dieting and use of weight-loss supplements within 6 months before pregnancy were excluding factors.
No dietary recommendations were given. Exclusion criteria for the follow-up study were pregnancy during the last 12 months or a history of diabetes, neurological, hepatic or renal disease or a major psychiatric disorder. Four participants were pregnant between these two studies. The mean follow-up time was 5 ± 1 years after the latest pregnancy. This time span was chosen to ensure that the women were past the postpartum stage and were not breastfeeding.
F I G U R E 1 Cohort and protocol. Women were evaluated at caesarean section and 5 ± 1 y after delivery. At analysis, the women were divided into quartiles depending on weight development from the start of pregnancy. At follow-up, weight gain as percentage of body weight was calculated from the start of pregnancy to follow-up and used to identify groups of weight gain or weight stability. The women who gained most (highest quartile) were named weight gain, and the rest weight stable.
| Protocol
After an overnight fast, venous blood and CSF were collected. For CSF, an introducer needle was inserted into the interspinous ligament at L3-4, and a 25-gauge Whitacre needle or a 25-gauge Pajunk Pencil Point Spinal Needle was inserted through the introducer into the subarachnoid space. Ten millilitres CSF was removed with a 10-mL syringe. The first 0.5 mL was discarded. Study samples were centrifuged, aliquoted and stored (−80°C) as described. The total height of the gynoid region is two times the height of the android region. 
| Biochemical assays
| Statistical methods
Women were divided into two groups according to weight change from start of pregnancy to follow-up 5 ± 1 years after pregnancy.
Women in the highest quartile were assigned to the weight gain group (increased their weigh>9%). Remaining women were assigned to the weight stable group. Results are presented as median (interquartile range, IQR) in tables and as mean ± SD for the whole population in text. Differences between the groups were analysed using
Mann-Whitney U test. For longitudinal comparisons (pregnancy to follow-up), Wilcoxon signed-ranked test was used. Pearson correlations for body composition and neuropeptides were calculated for the whole population. Univariate logistic regression analyses were performed for each pregnancy variable reported in Tables 1   and 2 individually to predict the odds of pertaining to the weight gain group. As only one variable (AgRP) was significant, no multivariate analyses were done. For determination of Michaelis-Menten type kinetics for saturable transport of leptin, all measurements from our previous pregnancy study were included (n = 58), 7 and a nonlinear regression analysis was done with the following model:
. P < .05 was considered significant.
| RESULTS
| Subjects
Characteristics of the subjects divided into two groups depending on weight development are shown in Table 1 . Prepregnancy BMI did not differ between groups, but insulin resistance (HOMA-IR) during pregnancy was higher in the weight gain group. After pregnancy, the weight gain group had a higher BMI and more body fat, but insulin resistance did not differ in the two groups. The groups did not differ in gestational weight gain, age, parity or time since pregnancy at the follow-up or in the duration of breastfeeding.
| S-AgRP during pregnancy predicts weight change
S-AgRP levels during pregnancy were lower in the weight stable group (P < .001, Table 2 ). By logistic regression analysis, an increase of 1 unit in s-AgRP was associated with 24% higher odds of pertaining to the weight gain group (P = .04). After pregnancy, s-AgRP increased in the weight stable group (P = .02) but decreased in the weight gain group (P = .02); at follow-up, the levels were similar in the two groups (Table 2 , and changes in Figure 2 ). CSF-AgRP did not differ between groups and did not change from pregnancy to follow-up.
| CSF:serum leptin levels increase after pregnancy only in weight-stable women
S-leptin decreased after pregnancy in the weight stable group (P = .01) and the whole population (P = .002) but remained high in the weight gain group at follow-up (P = .02). CSF-leptin was similar in both groups and did not change after pregnancy. As shown by the CSF:serum ratio, transport of leptin into CNS increased significantly after pregnancy in the weight stable group (P = .01) and the whole population (P = .01).
LepR levels, analysed in nine samples, were significantly decreased after pregnancy (P = .01, Table 2 ) and were lower in the weight gain group at follow-up (P = .01). LepR, thought to be involved in leptin transport, correlated negatively with both CSF-leptin (r = −.648, P = .005) and s-leptin (r=−.579, P = .002) and correlated positively with the CSF:serum leptin ratio (r = .528, P = .029).
| S-Adiponectin increases and S-Insulin decreases after pregnancy
S-adiponectin increased after pregnancy in weight stable group (P < .001) but not in weight gain group (Table 2 and Figure 2B ). At follow-up, adiponectin concentration correlated inversely with HOMA-IR (r = −.453, P = .026) and positively with the leptin CSF:serum ratio (r = .559, P = .020). Adiponectin and AgRP concentrations changed similarly after pregnancy, and changes in AgRP and changes in adiponectin from pregnancy to follow-up correlated (r = .597, P = .005), even after adjustment for BMI at follow-up.
The adipokines, adiponectin and leptin, expressed as a ratio, increased in the weight stable group after pregnancy (P < .001).
The ratio did not increase in the weight gain group and was significantly lower than in the weight stable group at follow-up (P = .01) ( Table 2 and Figure 2C ). The adiponectin:leptin ratio also correlated negatively with HOMA-IR at follow-up (r = −.503, P = .012).
S-Insulin decreased after pregnancy in all women (P = .02) and weight gain group (P = .02). CSF insulin did not change significantly (Table 2 ).
| Peptide, hormone and adipokine correlations to body composition at follow-up
The relationship between hormones and body composition is displayed in Table 3 . Leptin correlated best with all body fat parameters, as judged from CSF and serum levels and the CSF:serum ratio. Serum insulin correlated strongly with all body fat measurements, whereas CSF insulin only correlated with android fat and the android:gynoid fat ratio. Serum adiponectin and s-AgRP showed similar correlations, with negative correlations only to android fat and the adroid:gynoid fat ratio. LepR had strong negative correlations with whole-body, android and gynoid fat. 
Time since last pregnancy (years)
5 (4-6) 6 (5-6) 6 (4-6)
Breastfeeding exclusive (months)
Breastfeeding total (months)
(3-14) 6 (3-9) 7 (4-13)
Values are median (IQR). *P < .05, **P < .01, and ***P < .001 vs Weight-stable (Mann-Whitney U test).
T A B L E 1 Maternal characteristics of the weight stable and weight gain groups based on weight changes from the start of pregnancy to follow-up 5 ± 1 y later 
| Saturable transport kinetics is displayed for leptin but not AgRP
| DISCUSSION
This study suggests that peripheral AgRP levels in late pregnancy and changes in peripheral AgRP after pregnancy might predict long-term weight changes. We also confirmed earlier reports of decreased leptin transport into the CSF during pregnancy by showing that CSF:serum ratio increased after pregnancy, most clearly in women who returned to their prepregnancy weight. The leptin ratio correlated with soluble LepR (sLepR) levels, indicating an influence on leptin transport across the blood brain barrier (BBB). S-adiponectin increased after pregnancy Values are median (IQR). *P < .05, **P < .01, and ***P < .001 vs Weight-stable (Mann-Whitney U test). † P < .05, † † P < .01 and † † †
P < .001 vs Pregnancy (Wilcoxon signed-rank t test).
T A B L E 2 Levels of AgRP, leptin, insulin, adiponectin and leptin receptor in serum and CSF during pregnancy and at follow-up in weight stable and weight gain groups in the women who were weight stable and correlated negatively with HOMA-IR.
S-AgRP levels in late pregnancy were lower in the weight stable than in the weight gain group. By logistic regression analysis, s-AgRP was found to predict weight retention after pregnancy. S-AgRP also correlated negatively with android fat at follow-up. After pregnancy, sAgRP increased in the weight stable group but decreased in the weight gain group; at follow-up, both groups had similar levels.
AgRP, in its intact form, crosses the BBB into the human brain much slower than the saturably transported leptin, and slower than almost all other nonsaturably transported neurotrophins or endogenous peptides. 9 This passage is not self-inhibited by excess AgRP given by intravenous injection, indicating the absence of a saturable transport system, and is not cross-inhibited by leptin or α-MSH. The small amount of AgRP that crossed the BBB did so in intact form to the brain parenchyma rather than binding to capillary endothelial cells.
9
These findings are consistent with our results showing no relationship between CSF and s-AgRP in pregnant or nonpregnant states.
The slow transport across the BBB has been suggested to explain why intracerebroventricular injections of AgRP reduce energy expenditure and stimulate food intake more effectively than short exposure to peripheral AgRP. 10 It has been shown that a single peripheral bolus AgRP may have a less potent acute effect on food intake and energy expenditure than centrally administered AgRP 11 but
could have important regulatory roles in situations such as fasting and in exercise. 12, 13 After intravenous injection, radiolabeled AgRP enters peripheral organs at different rates, all of which are higher than the rate of entry into spinal cord and brain; the most rapid entry is into liver and adrenal gland. 10 These data open up the possibility for a broader role by AgRP not only in appetite but also in the regulation of energy balance through its actions on peripheral tissues.
F I G U R E 2
Changes in (A) serum AgRP, (B) serum adiponectin and (C) serum adiponectin:leptin ratio from pregnancy to follow-up for weight change groups. Individual values plotted with marker displaying mean value. *P < .05, **P < .01 and ***P < .001 between groups (Mann-Whitney U test) Significant correlations in bold (P<0.05).
In our study, CSF-AgRP at follow-up did not differ between groups and did not change from pregnancy values suggesting a fixed individual set point. In our previous study, 7 circulating AgRP levels increased during pregnancy, probably reflecting placental release, so we expected to find a decrease postpartum in all women. Instead, AgRP was higher at the 5-year follow-up in the weight-stable women.
Although the expression of AgRP mRNA is highest in the hypothalamus, the second highest concentration of AgRP mRNA is detected in adrenal glands followed by lungs but has also been found in kidneys and gonads in humans. 14 Taking into consideration the very slow passage over the BBB, it is unlikely that hypothalamus is the main source of AgRP after such a short time span. It might be that the other AgRP producing organs maintained or increased their synthesis to reach an individual set point and in this way contribute to the long-term regulation of body weight.
Our findings show a relationship between serum and CSF-leptin that indicates saturable transport into CSF. Earlier studies in humans and mice showed saturation at serum leptin levels similar to those in our study, indicating that leptin transport into the BBB is most effective at low circulating levels. 15 During pregnancy, increased food intake and increased fat deposits in the presence of hyperleptinemia suggest that gestation is a state of physiological resistance to leptin.
In pregnant rats, central resistance to leptin results from both an alteration in the hypothalamic regulation of intracellular leptin and a reduction in transport of leptin across the BBB. 16 Consistent with reduced leptin transport into the brain, the CSF:plasma leptin ratio is lower in pregnant women than in nonpregnant women. 17 This putative transitory reduction in the suppressive effects of leptin on food intake during pregnancy has not, to our knowledge, been shown in the same women in pregnant and nonpregnant states. Our serum and CSF-leptin data showed a higher K m value during pregnancy (although not significant), consistent with a lower saturation concentration and reduced transport across the BBB. CSF-leptin did not change after pregnancy, suggesting that leptin may also be less effective in suppressing the orexigenic effect of AgRP from changes in leptin signalling in the hypothalamus. In accordance with our results, another study found no differences in CSF-leptin levels between pregnant and nonpregnant women.
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Circulating leptin levels decreased after pregnancy in weightstable women; however, the decrease in women who gained weight was smaller. The CSF:serum leptin ratio increased significantly only in the weight stable group at follow-up. In obese humans, leptin transport across the BBB is reduced, 18 indicating that decreased passage of leptin into the CNS is a general mechanism of leptin resistance.
Leptin, a 16-kDa protein, is too large to diffuse across this barrier, but the soluble short form of the LepR, sLepR, might participate in leptin transport across the BBB.
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SLepR was significantly reduced after pregnancy, and the lowest follow-up concentrations were in women who gained weight. SLepR correlated strongly and negatively with CSF-leptin and s-leptin, and positively with the CSF:serum ratio at follow-up, in agreement with a recent study. 20 SLepR also showed strong negative correlations with whole-body, android and gynoid fat depots. Increased expression of sLepR is associated with lower body weight in murine models, suggesting the important role of sLepR in leptin regulation.
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Serum adiponectin increased after pregnancy in all women and was significantly higher in the weight stable group. At follow-up, adiponectin concentration correlated inversely with HOMA-IR and with both android fat and the android:gynoid fat ratio representing an increased visceral adipose tissue depot. Lower levels of adiponectin have been reported associated with insulin resistance, such as in visceral obesity. 22 Circulating adiponectin and AgRP levels also increased similarly and correlated strongly from pregnancy to follow-up, even after adjustment for BMI.
Pregnancy is characterized by increased insulin resistance 23 and release of the major regulatory cytokines adiponectin and leptin from adipose tissue. During the third trimester, circulating adiponectin levels decrease in parallel with maternal insulin sensitivity. 24 In one study, adiponectin genes were expressed mainly in adipose tissue during pregnancy, and adiponectin levels were lower in obese women than in lean women. 25 Although body fat mass and fat depots were not measured, plasma adiponectin also correlated negatively with insulin sensitivity and maternal BMI, in agreement with our findings.
Decreased adiponectin and increased leptin concentrations reduce the adiponectin:leptin ratio and are associated with increased insulin resistance in obesity and type 2 diabetes. 26, 27 In our study, the adiponectin:leptin ratio at follow-up increased significantly in the weight stable group but not in the weight gain group. The ratio also correlated strongly with body fat and android and gynoid fat depots. Consistent with our findings, the utility of the adiponectin:leptin ratio as a potential noninvasive biomarker of insulin resistance has also been shown in pregnancy. Specifically, the insulin resistance index correlated inversely with the adiponectin:leptin ratio and the ratio during pregnancy has been shown to correlate inversely with prepregnancy BMI. 28 As expected, the serum and CSF insulin ratio increased after pregnancy, although not significant, and in accordance with pregnancy being an insulin resistant state, with lower serum and CSF insulin ratio.
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In a recent study, adiponectin, AgRP, leptin and LepR levels correlated with anthropometric parameters of adiposity in obese women and men. 30 To evaluate possible adipokine synergism, multiple indices of adipokine interactions were calculated. The results suggested that particularly AgRP and LepR in combination with other adipokines such as adiponectin may better reflect functional effects, especially with respect to influence on adipose tissue metabolism and prediction of body composition in specific groups of patients.
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| CONCLUSION
We found, in the same women, in both pregnant and nonpregnant states, that peripheral AgRP levels in late pregnancy may predict weight change after pregnancy after several years, also correlating with fat depots after pregnancy. In addition, the relationship between leptin and adiponectin might be physiologically important in this prediction. These results open a new field for further research on neurotransmitters and interaction with peripheral adipokines for long-term regulation of body weight and its underlying mechanisms.
